Vanessa Raabe

From the University of Rochester and Rochester General Hospital, Rochester (E.E.W., A.R.F.), Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.K., D.C., K.R.T., P.R.D., K.U.J., W.C.G.), and New York University Langone Vaccine Center and Grossman School of Medicine, New York (M.J.M., V.R.) — all in New York; Cincinnati Children’s Hospital, Cincinnati (R.W.F.); Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); the University of...

ORCID: 0000-0003-2579-1104

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults”.

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Nature(2020)10.1038/s41586-020-2639-4

N/A

9.3DataRank · unranked

1589 citations

Kirsten E. Lyke, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart +20 more

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

New England Journal of Medicine(2020)10.1056/nejmoa2027906

N/A

1.2DataRank · unranked

2718 citations

Robert W. Frenck, Ann R. Falsey, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman +23 more

Cellular and humoral immunity to Ebola Zaire glycoprotein and viral vector proteins following immunization with recombinant vesicular stomatitis virus-based Ebola vaccine (rVSVΔG-ZEBOV-GP)

Vaccine(2023)10.1016/j.vaccine.2023.01.059

N/A

0.655DataRank · unranked

15 citations

Lilin Lai, Juliet Morales, Yongxian Xu, Nadine Rouphael, Richard T. Davey +2 more

Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model Inoculum

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac045

N/A

0.543DataRank · unranked

13 citations

Allison Beck, Amy Kirby, Pengbo Liu, Muktha S. Natrajan, Lilin Lai +19 more

Safety and immunogenicity of a delayed booster dose of the rVSVΔG-ZEBOV-GP vaccine for prevention of Ebola virus disease: a multicentre, open-label, phase 2 randomised controlled trial

The Lancet Microbe(2024)10.1016/s2666-5247(24)00163-0

N/A

0.393DataRank · unranked

8 citations

Gary Collins, Nadine Rouphael, Guillaume Poliquin, Rosemary McConnell, Gabrielle Grubbs +21 more

A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults

Clinical Infectious Diseases(2024)10.1093/cid/ciae173

N/A

0.384DataRank · unranked

11 citations

Robert L. Atmar, Emmanuel B. Walter, Sharon E. Frey, Jeffery L. Meier, Amy C Sherman +23 more

Sequencing identifies multiple early introductions of SARS-CoV-2 to the New York City Region

medRxiv(2020)10.1101/2020.04.15.20064931

N/A

0DataRank · unranked

42 citations

Sitharam Ramaswami, Paul Zappile, Dacia Dimartino, Ludovic Boytard, André M. Ribeiro-dos-Santos +40 more

Cellular and Humoral Immunity to Ebola Zaire Glycoprotein and Viral Vector Proteins Following Immunization with Recombinant Vesicular Stomatitis Virus-Based Ebola Vaccine (rVSVΔG-EBOV-GP)

medRxiv(2021)10.1101/2021.11.09.21266118

N/A

0DataRank · unranked

0 citations

Lilin Lai, Juliet Morales, Yongxian Xu, Nadine Rouphael, Richard T. Davey +2 more

A Pediatric Infectious Diseases Perspective of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Novel Coronavirus Disease 2019 (COVID-19) in Children

Journal of the Pediatric Infectious Diseases Society(2020)10.1093/jpids/piaa099

N/A

0DataRank · unranked

44 citations

Alice I. Sato, Carol Kao, Felice C. Adler‐Shohet, Surabhi B Vora, Jeffery J. Auletta +19 more

Immunological Cross-Reactivity to Dengue Virus among Persons with Neuroinvasive West Nile Virus Infection

medRxiv(2022)10.1101/2022.01.03.22268686

N/A

0DataRank · unranked

1 citations

Muktha S. Natrajan, Chris Huerta, Yongxian Xu, Lilin Lai, Mark J. Mulligan +1 more

Hydroxychloroquine pre-exposure prophylaxis to prevent SARS-CoV-2 among health care workers at risk for SARS-CoV-2 exposure: A nonrandomized controlled trial

medRxiv(2022)10.1101/2022.07.01.22277058

N/A

0DataRank · unranked

0 citations

Andrew Fleming, Marie I. Samanovic, Lilin Lai, Hayley M. Belli, Mark J. Mulligan +2 more

Hydroxychloroquine Pre-Exposure Prophylaxis to Prevent SARS-CoV-2 Among Health Care Workers at High Risk For SARS-CoV-2 Exposure: A Nonrandomized Controlled Trial

Infectious Diseases Diagnosis & Treatment(2022)10.29011/2577-1515.100201

N/A

0DataRank · unranked

0 citations

Vanessa Raabe

Treating COVID-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind Randomized Controlled Trial in Hospitalized Patients

Open Forum Infectious Diseases(2020)10.1093/ofid/ofaa446

N/A

0DataRank · unranked

69 citations

Andrea B. Troxel, Ellie Carmody, Jaishvi Eapen, Martín Bäcker, Jack DeHovitz +13 more

RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study

medRxiv(2020)10.1101/2020.08.17.20176651

N/A

0DataRank · unranked

155 citations

Robert W. Frenck, Ann R. Falsey, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman +20 more

Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model Inoculum

UNC Libraries(2024)10.17615/41dn-ky49

N/A

0DataRank · unranked

0 citations

Natrajan M.S, Jill El-Khorazaty, Nadine Rouphael, Kirby A.E, Collins M.H +19 more

Sequencing identifies multiple early introductions of SARS-CoV-2 to the New York City region

Genome Research(2020)10.1101/gr.266676.120

N/A

0DataRank · unranked

87 citations

Sitharam Ramaswami, Paul Zappile, Dacia Dimartino, Ludovic Boytard, André M. Ribeiro-dos-Santos +40 more